共 53 条
[1]
Murphy D(2016)Trends in Prevalence of Chronic Kidney Disease in the United States Ann Intern Med 165 473-481
[2]
Waikar SS(2018)Biological Variability of Estimated GFR and Albuminuria in CKD Am J Kidney Dis 72 538-546
[3]
Bellasi A(2012)Vascular imaging in chronic kidney disease Curr Opin Nephrol Hypertens 21 382-388
[4]
Raggi P(2005)Accuracy of Computed Tomographic Angiography and Magnetic Resonance Angiography for Diagnosing Renal Artery Stenosis Perspectives in Vascular Surgery and Endovascular Therapy 17 180-182
[5]
Josephs SC(2009)Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm Curr Opin Nephrol Hypertens 18 519-525
[6]
Perazella MA(2018)Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists Can Assoc Radiol J 69 136-150
[7]
Schieda N(2008)Magnetic resonance angiography (MRA) in renally impaired patients: when and how Eur J Radiol 66 213-219
[8]
Bongartz G(2016)Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD Am J Kidney Dis 67 984-988
[9]
Mayr M(2019)Noncontrast MR angiography: An update J Magn Reson Imaging 49 355-373
[10]
Bilecen D(2009)Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int 75 465-474